semaglutide sickness Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Patel it Like it is:

Support reaches out for renewals and handles non-medical questions like billing or shipping

References Wilson L, Zhao Z, Divino V, et al

In an analysis of all randomized participants regardless of fibrosis stage, significantly higher proportions receiving each dose of semaglutide than placebo had NASH resolution with no fibrosis worsening

With GLP-1 therapies like WEGOVY and ZEPBOUND showing dramatic weight-loss outcomes, many wonder if they could reduce or even replace the need for bariatric surgery

GLP-1 stimulates your body to release insulin, a hormone that helps move glucose, or sugar, from your blood into your cells for energy